Home > Annual Financials > CORAL LABORATORIES

CORAL LABORATORIES Financial Statement Analysis
[BOM: 524506]

The Revenues of CORAL LABORATORIES have increased by 7.09% YoY .
The Earnings Per Share (EPS) of CORAL LABORATORIES has increased by 53.00 % YoY.
COMMUNITY POLL
for CORAL LABORATORIES
Please provide your vote to see the results

CORAL LABORATORIES Last 5 Annual Financial Results
[BOM: 524506]

StandaloneMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹84 Cr₹78 Cr₹76 Cr₹97 Cr₹71 Cr
Expenses ₹67 Cr₹74 Cr₹67 Cr₹81 Cr₹65 Cr
Operating Profit (Excl OI) ₹16 Cr₹3.81 Cr₹8.21 Cr₹16 Cr₹5.42 Cr
Other Income ₹6.63 Cr₹6.90 Cr₹4.81 Cr₹3.77 Cr₹5.89 Cr
Interest ₹0.00 Cr₹0.34 Cr₹0.14 Cr₹0.04 Cr₹0.19 Cr
Depreciation ₹1.98 Cr₹2.18 Cr₹1.99 Cr₹1.98 Cr₹2.01 Cr
Profit Before Tax ₹21 Cr₹8.23 Cr₹12 Cr₹18 Cr₹9.12 Cr
Profit After Tax ₹16 Cr₹6.45 Cr₹9.05 Cr₹14 Cr₹7.13 Cr
Earnings Per Share (Rs)₹67.61₹44.19₹18.04₹25.32₹37.94
PAT Margin (%)21.0018.878.2511.9614.04
ROE(%)12.769.504.156.1810.74
ROCE(%)17.0412.485.417.8713.35
Total Debt/Equity(x)0.020.000.000.040.05

Key Financials

Market Cap : ₹ 154.6 Cr
Revenue (TTM) : ₹ 87.6 Cr
Net Profit(TTM) : ₹ 14.0 Cr
EPS (TTM) : ₹ 38.9
P/E (TTM) : 11.1

Industry Peers & Returns1W1M1Y
CORAL LABORATORIES -0.3% -3.7% -43.9%
SUN PHARMACEUTICAL INDUSTRIES 1.3% 8.9% 6%
DIVIS LABORATORIES 2.4% 6% 12.4%
CIPLA 1.9% 2% -8.7%
TORRENT PHARMACEUTICALS -0.6% 9.4% 44.1%
DR REDDYS LABORATORIES -0.4% 9.5% 10.5%
MANKIND PHARMA 9.3% 7.3% -2.3%
ZYDUS LIFESCIENCES 0.3% 3.2% 3.6%
LUPIN 2.7% 8.1% 21%


CORAL LABORATORIES Revenues
[BOM: 524506]

Y-o-Y

7.09 %

5 Yr CAGR

4.34 %

Years Revenues % Change
Mar2025 ₹84 Cr
7.09
Mar2024 ₹78 Cr
3.32
Mar2023 ₹76 Cr
-21.70
Mar2022 ₹97 Cr
36.82
Mar2021 ₹71 Cr -


CORAL LABORATORIES Operating Profit
[BOM: 524506]

Y-o-Y

326.00 %

5 Yr CAGR

31.55 %

Years Operating Profit % Change
Mar2025 ₹16 Cr
326.00
Mar2024 ₹3.81 Cr
-53.59
Mar2023 ₹8.21 Cr
-48.17
Mar2022 ₹16 Cr
192.26
Mar2021 ₹5.42 Cr -

Operating Margins
Y-o-Y

297.75 %

5 Yr CAGR

26.09 %

Years Operating Margin% % Change
Mar2025 19.41%
297.75
Mar2024 4.88%
-55.06
Mar2023 10.86%
-33.82
Mar2022 16.41%
113.67
Mar2021 7.68% -

CORAL LABORATORIES Profit After Tax
[BOM: 524506]

Y-o-Y

144.98 %

5 Yr CAGR

21.99 %

Years Profit After Tax % Change
Mar2025 ₹16 Cr
144.98
Mar2024 ₹6.45 Cr
-28.75
Mar2023 ₹9.05 Cr
-33.26
Mar2022 ₹14 Cr
90.11
Mar2021 ₹7.13 Cr -

PAT Margins
Y-o-Y

11.29 %

5 Yr CAGR

10.59 %

Years PAT Margin(%) % Change
Mar2025 21 %
11.29
Mar2024 18.87 %
128.73
Mar2023 8.25 %
-31.02
Mar2022 11.96 %
-14.81
Mar2021 14.04 % -

CORAL LABORATORIES Earnings Per Share (EPS)
[BOM: 524506]

Y-o-Y

53.00 %

5 Yr CAGR

15.54 %

Years EPS % Change
Mar2025 ₹68
53.00
Mar2024 ₹44
144.96
Mar2023 ₹18
-28.75
Mar2022 ₹25
-33.26
Mar2021 ₹38 -

CORAL LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524506]

Y-o-Y

36.54 %

5 Yr CAGR

6.29 %

Years ROCE % Change
Mar2025 17.04%
36.54
Mar2024 12.48%
130.68
Mar2023 5.41%
-31.26
Mar2022 7.87%
-41.05
Mar2021 13.35% -

CORAL LABORATORIES Share Price vs Sensex

Current Share Price : ₹429.4
Current MarketCap: ₹ 154.6 Cr
Updated EOD on :Mar 02,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
CORAL LABORATORIES

-0.3%

-3.7%

-43.9%

SENSEX

-3.7%

-2.5%

6.5%

CORAL LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about CORAL LABORATORIES Financials


How the annual revenues of CORAL LABORATORIES have changed ?

The Revenues of CORAL LABORATORIES have increased by 7.09% YoY .

How the Earnings per Share (EPS) of CORAL LABORATORIES have changed?

The Earnings Per Share (EPS) of CORAL LABORATORIES has increased by 53.00 % YoY .